China Pharma Holdings Share Holder Equity 2010-2023 | CPHI
China Pharma Holdings share holder equity from 2010 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
China Pharma Holdings Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$7 |
| 2022 |
$4 |
| 2021 |
$6 |
| 2020 |
$8 |
| 2019 |
$9 |
| 2018 |
$30 |
| 2017 |
$43 |
| 2016 |
$59 |
| 2015 |
$73 |
| 2014 |
$93 |
| 2013 |
$133 |
| 2012 |
$149 |
| 2011 |
$142 |
| 2010 |
$118 |
| 2009 |
$88 |
China Pharma Holdings Quarterly Share Holder Equity
(Millions of US $) |
| 2023-12-31 |
$7 |
| 2023-09-30 |
$6 |
| 2023-06-30 |
$4 |
| 2023-03-31 |
$5 |
| 2022-12-31 |
$4 |
| 2022-09-30 |
$3 |
| 2022-06-30 |
$4 |
| 2022-03-31 |
$5 |
| 2021-12-31 |
$6 |
| 2021-09-30 |
$7 |
| 2021-06-30 |
$7 |
| 2021-03-31 |
$7 |
| 2020-12-31 |
$8 |
| 2020-09-30 |
$8 |
| 2020-06-30 |
$8 |
| 2020-03-31 |
$8 |
| 2019-12-31 |
$9 |
| 2019-09-30 |
$27 |
| 2019-06-30 |
$29 |
| 2019-03-31 |
$31 |
| 2018-12-31 |
$30 |
| 2018-09-30 |
$38 |
| 2018-06-30 |
$41 |
| 2018-03-31 |
$44 |
| 2017-12-31 |
$43 |
| 2017-09-30 |
$57 |
| 2017-06-30 |
$57 |
| 2017-03-31 |
$58 |
| 2016-12-31 |
$59 |
| 2016-09-30 |
$65 |
| 2016-06-30 |
$67 |
| 2016-03-31 |
$72 |
| 2015-12-31 |
$73 |
| 2015-09-30 |
$81 |
| 2015-06-30 |
$95 |
| 2015-03-31 |
$88 |
| 2014-12-31 |
$93 |
| 2014-09-30 |
$115 |
| 2014-06-30 |
$121 |
| 2014-03-31 |
$129 |
| 2013-12-31 |
$133 |
| 2013-09-30 |
$143 |
| 2013-06-30 |
$144 |
| 2013-03-31 |
$147 |
| 2012-12-31 |
$149 |
| 2012-09-30 |
$149 |
| 2012-06-30 |
$148 |
| 2012-03-31 |
$146 |
| 2011-12-31 |
$142 |
| 2011-09-30 |
$138 |
| 2011-06-30 |
$131 |
| 2011-03-31 |
$124 |
| 2010-12-31 |
$118 |
| 2010-09-30 |
$111 |
| 2010-06-30 |
$103 |
| 2010-03-31 |
$97 |
| 2009-12-31 |
$88 |
| 2009-09-30 |
$85 |
| 2009-06-30 |
$78 |
| 2009-03-31 |
$74 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.005B |
$0.007B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
